Evaluation of potential serum biomarkers for individuals at risk of multiple sclerosis highlights SPP1.
Investigating whether alterations in six previously MS-associated biomarkers are detectable and associated with underlying genetic susceptibility in two independent sample collections suggest that several circulating proteins recently proposed as MS biomarkers are not robust tools to distinguish MS from healthy individ...